Stockreport

Y-mAbs Therapeutics Inc (YMAB) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... [Yahoo! Finance]

Y-mAbs Therapeutics, Inc.  (YMAB) 
Last y-mabs therapeutics, inc. earnings: 11/13 04:01 pm Check Earnings Report
PDF Ex-US Danyelza Net Product Revenues: $3.1 million in Q3 2024, a 19% decrease from Q3 2023. Total Net Revenue for First Nine Months: $61.2 million, relatively consiste [Read more]